Bipin Patel is CEO & Founder of electronRx, a deep tech team of interdisciplinary scientists and engineers developing novel technologies to sense the physiological environment and inform personalized therapeutic interventions. Dr. Patel is an entrepreneur with over 20 years of biomedical engineering, drug development and commercialization experience. He previously held leadership roles at big pharma like Merck KGaA, GSK and Pierre Fabre.
Biological clocks could play an important role in helping to promote healthy ageing and to stem the growing incidence of age-related diseases by improving the quality of life of the aged, reducing mortality and relieving the burden on overwhelmed health and social care resources.
There is an urgent need to develop solutions that can enable the early diagnosis of COPD as any delays in the diagnosis of COPD represent a missed opportunity to slow disease progression through preventative interventions. Smoking cessation alone could save as many as 120,000 lives per year in the US alone.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
By placing the power to detect atrial fibrillation into the hands of 6 billion global smartphone users, validation of further physiological parameters will be expedited and the subsequent adoption of this technology into DTx will enable the low-cost tools required to remove barriers to care and improve heart health across the globe.
The key challenge for primary care is the current lack of means for population-wide screening as this significantly lowers our ability to catch the condition early in patients within this golden window.
Vagus nerve stimulation devices still have a long way to go, but the therapeutic potential of the vagus nerve, the advent of AI and machine learning in healthcare and the opportunity to establish truly personalized digital medicine are enough to warrant further exploration into VNS.
ED crowding is therefore an issue in the healthcare landscape where desperate need for change is meeting huge potential for innovation, and an international consortium should be formed to capitalize on this convergence.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Establishing digital biomarkers which correlate physiological parameters with mental health and wellbeing not only has the potential to provide more reliable tools for guiding diagnosis and evaluating patient outcomes but will also improve our understanding of the pathophysiology of mental disorders